Rafferty Asset Management, LLC
Position in AVXL — Anavex Life Sciences Corp.
CIK 1389426
New York, NY
Position in AVXL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$441,312
-$115,119 QoQ
Shares Held
143,750
-8.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. AVXL ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in AVXL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $441,312 | 143,750 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $556,431 | 156,301 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $965,009 | 108,428 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $849,567 | 92,144 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,093,555 | 127,454 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $801,214 | 74,601 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $792,848 | 139,586 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $946,605 | 224,314 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,410,020 | 669,945 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,160,208 | 232,031 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,773,661 | 270,788 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,850,882 | 350,662 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,987,235 | 465,255 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,303,622 | 464,754 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,837,442 | 274,946 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,679,838 | 167,816 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,531,298 | 368,099 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,212,128 | 242,914 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,991,044 | 166,632 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,847,086 | 168,289 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,778,706 | 118,977 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||